COVID-19 Pneumonia during Hydroxychloroquine Treatment of Rheumatoid Arthritis

被引：0
|
作者：
Gursoy, Canan [1 ]
Tapan, Ozge Oral [2 ]
Dogan, Emrah [3 ]
Togan, Turhan [4 ]
Demirbilek, Semra Gumus [1 ]
机构：
[1] Mugla Sitki Kocman Univ Training & Res Hosp, Dept Anesthesiol & Reanimat, Div Intens Care Unit, Mugla, Turkey
[2] Mugla Sitki Kocman Univ, Dept Lung Dis, Mugla, Turkey
[3] Mugla Sitki Kocman Univ, Dept Radiol, Mugla, Turkey
[4] Mugla Sitki Kocman Univ, Dept Infect Dis, Mugla, Turkey
来源：
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2020年 / 30卷 / 10期
关键词：
Coronavirus; Hydroxychloroquine; Prophylaxis; Rheumatoid arthritis; COVI-19; CHLOROQUINE;
D O I：
10.29271/jcpsp.2020.Supp2.S168
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The recently emerged and novel coronavirus, severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), that caused the current global pandemic was detected for the first time in Turkey in March 2020. While it continues to spread rapidly worldwide, there are still many uncertainties in the prevention and treatment of new coronavirus disease. We report a case of coronavirus disease 2019 (COVID-19) pneumonia in a patient under hydroxychloroquine (HCQ) treatment for rheumatoid arthritis. A 38-year female patient developed severe respiratory distress with SARS-CoV-2 infection and was treated in Intensive Care Unit (ICU). With this report, we aim to discuss the place of HCQ in prophylaxis in the light of the literature with a case presentation of COVID-19 pneumonia under HCQ treatment.
引用
收藏
页码：S168 / S170
页数：3
相关论文
共 50 条
  • [21] Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
    Fernando, Emmaline Zantua
    Yu, Jeryl Ritzi Tan
    Santos, Salvador Miclat Abad
    Jamora, Roland Dominic Go
    JOURNAL OF MOVEMENT DISORDERS, 2021, 14 (01) : 75 - 77
  • [22] Hydroxychloroquine shortages during the COVID-19 pandemic
    Mendel, Arielle
    Bernatsky, Sasha
    Thorne, J. Carter
    Lacaille, Diane
    Johnson, Sindhu R.
    Vinet, Evelyne
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03)
  • [23] BET 2: HYDROXYCHLOROQUINE IN THE TREATMENT OF COVID-19
    Howard, Laura
    Baombe, Janos
    Reynard, Charles
    EMERGENCY MEDICINE JOURNAL, 2020, 37 (07) : 451 - 453
  • [24] Chloroquine and Hydroxychloroquine in Treatment of COVID-19 Disease
    Yildirim, Fatma
    JOURNAL OF CRITICAL & INTENSIVE CARE, 2020, 11 : 23 - 26
  • [25] Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
    Shetty, Rajesh M.
    Namachivayam, ArunKumar
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (04) : 441 - 452
  • [26] Rethinking the role of hydroxychloroquine in the treatment of COVID-19
    Meyerowitz, Eric A.
    Vannier, Augustin G. L.
    Friesen, Morgan G. N.
    Schoenfeld, Sara
    Gelfand, Jeffrey A.
    Callahan, Michael V.
    Kim, Arthur Y.
    Reeves, Patrick M.
    Poznansky, Mark C.
    FASEB JOURNAL, 2020, 34 (05): : 6027 - 6037
  • [27] Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
    Singh, Bhagteshwar
    Ryan, Hannah
    Kredo, Tamara
    Chaplin, Marty
    Fletcher, Tom
    EMERGENCIAS, 2022, 34 (04): : 305 - 307
  • [28] Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
    Hennekens, Charles H.
    Rane, Manas
    Solano, Joshua
    Alter, Scott
    Johnson, Heather
    Krishnaswamy, Shiv
    Shih, Richard
    Maki, Dennis
    DeMets, David L.
    AMERICAN JOURNAL OF MEDICINE, 2022, 135 (01): : 7 - 9
  • [29] Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
    Singh, Bhagteshwar
    Ryan, Hannah
    Kredo, Tamara
    Chaplin, Marty
    Fletcher, Tom
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (02):
  • [30] Risk of using hydroxychloroquine as a treatment of COVID-19
    Alanagreh, Lo'ai
    Alzoughool, Foad
    Atoum, Manar
    INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE, 2020, 31 (03): : 111 - 116
12345